Back to results

RecruitingPhase 2

Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer

NCT04965766

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Centre Georges François Leclerc

Dijon, France

+10 additional locations

Contact

Barbara PISTILLI, MD

+33 (0)1 42 11 42 11 barbara.pistilli@gustaveroussy.fr

View on ClinicalTrials.gov

Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer — TrialFind